Drug Trial Radar · NCT04854668
A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
Last checked: Nov 19, 2026Latest source record: Jan 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
748
Actual
Start
May 27, 2021
Primary completion
Dec 31, 2024
Study completion Dec 2026
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open label, randomized, phase Ⅲ study to treat subjects with RAS/BRAF wild-type, unresectable metastatic colorectal cancer. The patients will be randomized into two arms consist of Anlotinib (3 weeks/cycle) + CapeOx and Bevacizumab (3 week/cycle) + CapeOx at a ratio of 1:1. This study is conducted to assess the efficacy and safety of Anlotinib and Chemotherapy as first-line treatment in subjects with RAS/BRAF wild-type Metastatic Colorectal Cancer.
Conditions
- Metastatic Colorectal Cancer
Interventions
Anlotinib hydrochloride capsuleDrug
Anlotinib hydrochloride capsule 12mg given orally in fasting conditions, once daily in 21-day cycle (14 days on treatment from Day 1-14, 7 days off treatment from Day 15-21);
BevacizumabDrug
Bevacizumab 7.5mg/kg, intravenous drip, on Day 1
OxaliplatinDrug
Oxaliplatin 130mg/m2, intravenous drip, on Day 1;
CapecitabineDrug
Capecitabine 850mg/m2 administrated orally twice daily from Day 1-14.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival (PFS) assessed by IRCTime frame: Baseline up to 15 months
Locations
92 sites in 1 country. Site status is shown where the registry gives one.
The People's Hospital of Chizhou
Chizhou, Anhui, China
Fujian Medical University Union Hospital
Fuzhou, Anhui, China
Anhui Provincial Hospital
Hefei, Anhui, China
Anhui Cancer Hospital
Hefei, Anhui, China
Xuancheng People's Hospital
Xuancheng, Anhui, China
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Peking University Frist Hospital
Beijing, Beijing Municipality, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Fuling Hospital Affiliated to Chongqing University
Chongqing, Chongqing Municipality, China
Fujian Cancer Hospital
Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
Gansu Provincial Cancer Hospital
Lanzhou, Gansu, China
Gansu Provincial Hospital
Lanzhou, Gansu, China
Lanzhou University Second Hospital
Lanzhou, Gansu, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, China
Qingyuan People's Hospital
Qingyuan, Guangdong, China
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
Liuzhou Workers' Hospital
Liuzhou, Guangxi, China
The Affiliated Cancer Hospital of Guizhou Medical University
Guiyang, Guizhou, China
Guizhou Provincial People's Hospital
Guiyang, Guizhou, China
The First Hospital of Qinhuangdao
Qinhuangdao, Hebei, China
Tangshan People's Hospital
Tangshan, Hebei, China
The First Affiliated Hospital of Hebei North University
Zhangjiakou, Hebei, China
Harbin Medical University Affiliated Cancer Hospital
Harbin, Heilongjiang, China
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Huaihe Hospital of Henan University
Kaifeng, Henan, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Nanyang Second General Hospital
Nanyang, Henan, China
Xinyang Central Hospital
Xinyang, Henan, China
Henan Cancer Hospital
Zhengzhou, Henan, China
The First Affiliated Hospital of ZhengZhou University
Zhengzhou, Henan, China
Tongji Hospital Affiliated to Tongji Medical College Hust
Wuhan, Hubei, China
Hubei Cancer Hospital
Wuhan, Hubei, China
Xiangyang Central Hospital
Xiangyang, Hubei, China
Hunan Cancer Hospital
Changsha, Hunan, China
Affiliated Hospital of Chifeng University
Chifeng, Inner Mongolia, China
Chifeng Municipal hospital
Chifeng, Inner Mongolia, China
Showing 40 of 92 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.